例如:"NBL1", "4681", "drought"
收藏
2288 FKBP4

2288

FKBP4

FKBP prolyl isomerase 4

protein-coding

Homo sapiens

基因描述

Type Description
Definition FKBP prolyl isomerase 4

研究结论

Date Results Publications
2020-10-24 14:07:00 FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer. 31660083
2020-05-23 10:05:00 The study therefore strongly implicates FKBP4 as associated with fetal losses in humans, particularly in the Asian population. 31504499
2019-10-19 10:56:00 elevated FKBP4 expression was associated with poor survival of patients with hormone-naive prostate cancer 29484655
2017-11-04 11:04:00 ID4 selectively regulates AR activity through direct interaction with FKBP52. 28252832
2017-09-30 10:56:00 FKBP52 could be abnormally released from NFTs negative neurons in AD brains in correlation with the early pathologic Tau-D(421) neuronal accumulation. 27479154

名称对应

Type IDs
Synonymous FKBP51, FKBP52, FKBP59, HBI, Hsp56, PPIase, p52
Gene
UniProtKB-ID: FKBP4_HUMAN
UniprotKB: Q02790
UniParc: UPI000013C4D0
EMBL: CH471116, BC001786, M88279, AC005841, BC007924
Ensembl: ENSG00000004478
KO: hsa:2288
Nucleutide sequences
EMBL-CDS: AAA36111.1, EAW88889.1, AAH01786.1, AAH07924.1, EAW88890.1
Ensembl_TRS: ENST00000001008
Protein sequencees
Ensembl_PRO: ENSP00000001008
RefSeq: NP_002005.1, XP_011519231.1
Others
UniRef100: UniRef100_Q02790
UniRef90: UniRef90_Q02790
UniRef50: UniRef50_Q02790
UniGene: Hs.524183, Hs.713721
CCDS: CCDS8512.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员